Shernell Elmander
Vice President of Investor Relations
Replay available
Zymeworks Inc. (NASDAQ: ZYME) Q4 2025 earnings conference call, held 2026-03-02. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations
Chair, CEO, and Interim Chief Financial Officer
Senior Vice President of Finance
Senior Vice President and Chief Medical Officer
Chief Scientific Officer
Acting Chief Investment Officer
Acting Chief Development Officer
Analyst, LifeSci Capital
Watch the replay and follow the connected company analysis, news, and investor updates for Zymeworks Inc..
WEBVTT 00:00:00.031 -- 00:00:03.635 Thank you for standing by. This is the conference operator. 00:00:03.635 -- 00:00:07.339 Welcome to DesignWorks' fourth quarter 2025 00:00:07.339 -- 00:00:12.525 results conference call and webcast. As a reminder, all participants are in listen-only 00:00:12.525 -- 00:00:15.268 mode, and the conference is being recorded. 00:00:15.268 -- 00:00:18.772 After the presentation, there will be an opportunity to ask questions. 00:00:18.772 -- 00:00:22.936 I would now like to turn the conference over to Shernell Elmander, Vice President of 00:00:22.936 -- 00:00:25.099 Investor Relations. Shernell, please go ahead. 00:00:25.099 -- 00:00:28.465 Thank you, operator, and good morning, everyone. 00:00:28.465 -- 00:00:33.111 Thank you for joining our fourth quarter 2025 results conference call. 00:00:33.111 -- 00:00:36.755 As usual, I'd like to remind you that we'll be making a number of forward-looking statements 00:00:36.755 -- 00:00:41.240 during this call, including without limitation, those forward-looking statements identified 00:00:41.240 -- 00:00:44.184 in our slides and the accompanying oral commentary. 00:00:44.184 -- 00:00:48.289 Forward-looking statements are based upon our current expectations and various assumptions 00:00:48.289 -- 00:00:52.554 and are subject to the risks and uncertainties, including those associated with the companies 00:00:52.554 -- 00:00:55.637 in our industry and at our stage of development. 00:00:55.637 -- 00:01:00.617 The discussion of these risks and uncertainties I refer you to the latest SEC findings 00:01:00.617 -- 00:01:04.481 as found on our website and as filed with the SEC. 00:01:04.481 -- 00:01:08.726 In a moment, I'll hand over the call to Ken Galbraith, our Chair, CEO, and Interim Chief 00:01:08.72...